0.03% Tacrolimus ointment applied once or twice daily is more efficacious than 1% hydrocortisone acetate in children with moderate to severe atopic dermatitis: results of a randomised double-blind controlled trial

S Reitamo; J Harper; JD Bos; F Cambazard; C Bruijnzeel-Koomen; P Valk; C Smith; Celia Moss; A Dobozy; R Palatsi

doi:10.1046/j.1365-2133.2004.05782.x

0.03% Tacrolimus ointment applied once or twice daily is more efficacious than 1% hydrocortisone acetate in children with moderate to severe atopic dermatitis: results of a randomised double-blind controlled trial

S Reitamo, J Harper, JD Bos, F Cambazard, C Bruijnzeel-Koomen, P Valk, C Smith, Celia Moss, A Dobozy, R Palatsi

Birmingham Medical School

Research output: Contribution to journal › Article

107 Citations (Scopus)

Original language	English
Pages (from-to)	554-562
Number of pages	9
Journal	British Journal of Dermatology
Volume	150
Issue number	3
DOIs	https://doi.org/10.1046/j.1365-2133.2004.05782.x
Publication status	Published - 1 Jan 2004

Access to Document

10.1046/j.1365-2133.2004.05782.x

Cite this

Reitamo, S., Harper, J., Bos, JD., Cambazard, F., Bruijnzeel-Koomen, C., Valk, P., Smith, C., Moss, C., Dobozy, A., & Palatsi, R. (2004). 0.03% Tacrolimus ointment applied once or twice daily is more efficacious than 1% hydrocortisone acetate in children with moderate to severe atopic dermatitis: results of a randomised double-blind controlled trial. British Journal of Dermatology, 150(3), 554-562. https://doi.org/10.1046/j.1365-2133.2004.05782.x

@article{75d9a337372f41e8ac7bc68ab74ceb83,

title = "0.03% Tacrolimus ointment applied once or twice daily is more efficacious than 1% hydrocortisone acetate in children with moderate to severe atopic dermatitis: results of a randomised double-blind controlled trial",

author = "S Reitamo and J Harper and JD Bos and F Cambazard and C Bruijnzeel-Koomen and P Valk and C Smith and Celia Moss and A Dobozy and R Palatsi",

year = "2004",

month = jan,

day = "1",

doi = "10.1046/j.1365-2133.2004.05782.x",

language = "English",

volume = "150",

pages = "554--562",

journal = "British Journal of Dermatology",

issn = "1365-2133",

publisher = "Wiley",

number = "3",

}

Reitamo, S, Harper, J, Bos, JD, Cambazard, F, Bruijnzeel-Koomen, C, Valk, P, Smith, C, Moss, C, Dobozy, A & Palatsi, R 2004, '0.03% Tacrolimus ointment applied once or twice daily is more efficacious than 1% hydrocortisone acetate in children with moderate to severe atopic dermatitis: results of a randomised double-blind controlled trial', British Journal of Dermatology, vol. 150, no. 3, pp. 554-562. https://doi.org/10.1046/j.1365-2133.2004.05782.x

0.03% Tacrolimus ointment applied once or twice daily is more efficacious than 1% hydrocortisone acetate in children with moderate to severe atopic dermatitis: results of a randomised double-blind controlled trial. / Reitamo, S; Harper, J; Bos, JD et al.
In: British Journal of Dermatology, Vol. 150, No. 3, 01.01.2004, p. 554-562.

Research output: Contribution to journal › Article

TY - JOUR

T1 - 0.03% Tacrolimus ointment applied once or twice daily is more efficacious than 1% hydrocortisone acetate in children with moderate to severe atopic dermatitis: results of a randomised double-blind controlled trial

AU - Reitamo, S

AU - Harper, J

AU - Bos, JD

AU - Cambazard, F

AU - Bruijnzeel-Koomen, C

AU - Valk, P

AU - Smith, C

AU - Moss, Celia

AU - Dobozy, A

AU - Palatsi, R

PY - 2004/1/1

Y1 - 2004/1/1

UR - http://www.scopus.com/inward/record.url?scp=11144358531&partnerID=8YFLogxK

U2 - 10.1046/j.1365-2133.2004.05782.x

DO - 10.1046/j.1365-2133.2004.05782.x

M3 - Article

C2 - 15030341

SN - 1365-2133

VL - 150

SP - 554

EP - 562

JO - British Journal of Dermatology

JF - British Journal of Dermatology

IS - 3

ER -

Reitamo S, Harper J, Bos JD, Cambazard F, Bruijnzeel-Koomen C, Valk P et al. 0.03% Tacrolimus ointment applied once or twice daily is more efficacious than 1% hydrocortisone acetate in children with moderate to severe atopic dermatitis: results of a randomised double-blind controlled trial. British Journal of Dermatology. 2004 Jan 1;150(3):554-562. doi: 10.1046/j.1365-2133.2004.05782.x